These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 13972651)
1. [Medical treatment of obesity]. QUAADE F Nord Med; 1963 Aug; 70():874-8. PubMed ID: 13972651 [No Abstract] [Full Text] [Related]
2. THE USES AND ABUSES OF APPETITE SUPPRESSANTS. SEATON DA; DUNCAN LJ Br J Clin Pract; 1965 Feb; 19():89-93. PubMed ID: 14258387 [No Abstract] [Full Text] [Related]
3. A COMPARISON OF THE APPETITE SUPPRESSING PROPERTIES OF DEXAMPHETAMINE AND PHENTERMINE. SEATON DA; ROSE K; DUNCAN LJ Scott Med J; 1964 Nov; 9():482-5. PubMed ID: 14231545 [No Abstract] [Full Text] [Related]
4. Comparison of benzphetamine, phenmetrazine, d-amphetamine, and placebo. PATEL N; MOCK DC; HAGANS JA Clin Pharmacol Ther; 1963; 4():330-3. PubMed ID: 13941813 [No Abstract] [Full Text] [Related]
5. Value of ephedrine-ethlenediamine as an appetite depressant: comparison with d-amphetamine sulfate. KUPERSMITH IH Curr Ther Res Clin Exp; 1960 Feb; 2():39-42. PubMed ID: 14412826 [No Abstract] [Full Text] [Related]
7. [SIMULTANEOUS RECORDING OF FOOD AND LIQUID UPTAKE AND MOTOR ACTIVITY IN RATS UNDER THE EFFECT OF DIFFERENT DRUGS]. SPENGLER J Helv Physiol Pharmacol Acta; 1964 Oct; 64():C146-7. PubMed ID: 14246289 [No Abstract] [Full Text] [Related]
9. Comparative study of anorectic activity of d-amphetamine, chlorphentermine and fenfluramine in aurothioglucose obese and non-obese mice. Abdallah AH Arch Int Pharmacodyn Ther; 1968 Dec; 176(2):395-402. PubMed ID: 5715411 [No Abstract] [Full Text] [Related]
10. A determination of the anorexigenic potential of dl-amphetamine, d-amphetamine, l-amphetamine and phentermine. Lawlor RB; Trivedi MC; Yelnosky J Arch Int Pharmacodyn Ther; 1969 Jun; 179(2):401-7. PubMed ID: 5367311 [No Abstract] [Full Text] [Related]
11. FAILURE OF DEXTROAMPHETAMINE SULFATE TO INFLUENCE EATING AND SLEEPING PATTERNS IN OBESE SCHIZOPHRENIC PATIENTS: CLINICAL AND PHARMACOLOGICAL SIGNIFICANCE. MODELL W; HUSSAR AE JAMA; 1965 Jul; 193():275-8. PubMed ID: 14310348 [No Abstract] [Full Text] [Related]
12. Double-blind clinical evaluation of mazindol, dextroamphetamine, and placebo in treatment of exogenous obesity. Defelice EA; Chaykin LB; Cohen A Curr Ther Res Clin Exp; 1973 Jul; 15(7):358-66. PubMed ID: 4198296 [No Abstract] [Full Text] [Related]
13. Double-blind trial of anorectic agents. Sproule BC Med J Aust; 1969 Feb; 1(8):394-5. PubMed ID: 4889477 [No Abstract] [Full Text] [Related]
14. Appetite control in pregnancy using combined prochlorperazine-dextroamphetamine. VIGLIONE JP Clin Med (Northfield); 1962 May; 69():1157-60. PubMed ID: 15445884 [No Abstract] [Full Text] [Related]
15. INTRAMUSCULAR DEXTRO-AMPHETAMINE SULFATE IN THE TREATMENT OF INTRACTABLE OBESITY AND ITS COMPLICATIONS. GILBERT DB Southwest Med; 1965 Aug; 46():249-52. PubMed ID: 14323339 [No Abstract] [Full Text] [Related]
16. On the role of norepinephrine in the anorectic effect of D-amphetamine in mice. Abdallah AH Arch Int Pharmacodyn Ther; 1971 Jul; 192(1):72-7. PubMed ID: 5093195 [No Abstract] [Full Text] [Related]
17. USE OF AN AMPHETAMINE-COMBINATION DRUG IN AN ANTI-OBESITY CLINIC. BERMAN MI; ANDERSON IR Md State Med J; 1965 Jan; 14():29-31. PubMed ID: 14233312 [No Abstract] [Full Text] [Related]
18. [ON THE DRUG THERAPY OF OBESITY]. NEUBERT D Z Arztl Fortbild (Berl); 1965 Feb; 54():134-46. PubMed ID: 14266804 [No Abstract] [Full Text] [Related]
19. TDrug therapy in obesity. Ruedy J Mod Treat; 1967 Nov; 4(6):1138-45. PubMed ID: 6080141 [No Abstract] [Full Text] [Related]
20. Benzphetamine in the management of obesity-controlled studies. PAVER RL Rocky Mt Med J; 1963 Feb; 60():37-9. PubMed ID: 13942074 [No Abstract] [Full Text] [Related] [Next] [New Search]